Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Moderna, COVID-19 and Northwestern University
Northwestern sues Moderna for patent infringement over COVID-19 vaccines
Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused the company of misusing the school's innovations to develop its blockbuster COVID-19 vaccine Spikevax.
Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology
Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle technology without permission in the development of its COVID-19 vaccines.
Moderna appropriated Northwestern research for COVID vaccine, lawsuit alleges
The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own researchers' technological breakthroughs.
GSK sues Moderna for US patent infringement over COVID, RSV vaccines
British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of violating GSK's patent rights in messenger RNA (mRNA) technology with its blockbuster COVID-19 vaccine Spikevax.
GSK takes mRNA patent fight to Moderna, suing over vaccines for COVID and RSV
Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK is targeting Moderna in a pair of lawsuits alleging the Massachusetts-ba | GSK is targeting Moderna in a pair of lawsuits claiming the mRNA specialist violated multiple patents with its vaccines Spikevax and mRESVIA.
British drugmaker sues Moderna for patent infringement related to mRNA vaccines
A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent rights in its mRNA technology used to develop its COVID-19 and RSV vaccines.
Northwestern sues Moderna for alleged patent infringement in COVID shots
Moderna is facing allegations that it misused innovations from researchers at Northwestern University to develop its mRNA COVID-19 vaccines, which became widely available to the public in 2021 to combat the pandemic.
2d
BioNTech and Moderna: A tale of two mRNA developers
Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...
Medpage Today on MSN
5d
Serena Williams' Surgery; Moderna Sued Over COVID Vax; Brighter Nights and Mortality
Retired tennis star Serena Williams said she underwent a procedure to remove a benign branchial cyst "the size of a small ...
3d
Moderna (MRNA) Receives a Hold from Jefferies
Jefferies analyst Michael Yee maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $55.00. The ...
2d
美国西北大学起诉Moderna侵犯LNP专利
作者:黄莺美国Moderna公司的专利官司持续不断。一周前,2024年10月12日,葛兰素史克公司(GSK)向美国特拉华州地方法院起诉Moderna,指控其COVID-19疫苗Spikevax以及今年5月份获得FDA批准的RNA呼吸道合胞病毒(RSV ...
3d
Moderna股价触及52周低点55.65美元,市场环境变化
Moderna ...
13h
on MSN
Is Moderna Inc. (MRNA) the Best QQQ Stock to Buy According to Analysts?
We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this article, we are going to take a ...
4d
葛兰素史克起诉Moderna侵犯mRNA专利的真实意图
作者:黄莺俗话说人红是非多。在新冠疫情期间,凭借mRNA疫苗大获成功的Moderna公司,从年营收只有几千万美元的公司,一举跨入年营收200亿美元的公司行列。而这为其也带来了越来越多的专利纠纷。2021年,Moderna与美国国立卫生研究院的mRNA ...
23h
Moderna (NASDAQ:MRNA) Earns Market Perform Rating from Analysts at Sanford C. Bernstein
Sanford C. Bernstein started coverage on shares of Moderna (NASDAQ:MRNA – Free Report) in a research note issued to investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
mRNA vaccine
COVID
NASDAQ
GSK
GlaxoSmithKline
Feedback